![Patrick L. Bobbitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Patrick L.
Bobbitt worked as a Vice President-Development at HemaQuest Pharmaceuticals, Inc. and as a Global Project Manager at ICOS Corp.
He also worked as a Director-Clinical Operations at CTI BioPharma Corp.
and Seagen Inc. Additionally, he completed his undergraduate degree at Lamar University.
Former positions of Patrick L. Bobbitt
| Companies | Position | End |
|---|---|---|
| SEAGEN INC. | Director/Board Member | 02/01/2008 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Corporate Officer/Principal | - |
| CTI BIOPHARMA CORP. | Chief Tech/Sci/R&D Officer | - |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Corporate Officer/Principal | - |
Training of Patrick L. Bobbitt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Lamar University
 Lamar University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Health Technology |
- Stock Market
- Insiders
- Patrick L. Bobbitt
